Zaloguj Zarejestruj się zadarmo

4SC AG organizacji Akcje w obiegu

Jaka jest wartość Akcje w obiegu organizacji 4SC AG?

Wartość Akcje w obiegu organizacji 4SC AG to 11.280M 22.31%

Jaka jest definicja Akcje w obiegu?

Akcje w obiegu (Shares float) jest częścią akcji korporacji, które znajdują się w rękach inwestorów publicznych, a nie w postaci zablokowanych zapasów.

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

Akcje w obiegu firm w Health Care sektor na XETRA w porównaniu do 4SC AG

Czym się zajmuję organizacja 4SC AG?

4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.

Firmy z akcje w obiegu podobne do 4SC AG